MetLife Investment Management’s Accendra Health ACH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $143K | Sell |
41,729
-754
| -2% | -$2.34K | ﹤0.01% | 2603 |
|
|
2026
Q1 | $96.9K | Sell |
42,483
-225
| -0.5% | -$518 | ﹤0.01% | 2557 |
|
|
2025
Q4 | $120K | Sell |
42,708
-2,572
| -6% | -$9.19K | ﹤0.01% | 2527 |
|
|
2025
Q3 | $217K | Hold |
45,280
| – | – | ﹤0.01% | 2274 |
|
|
2025
Q2 | $412K | Buy |
45,280
+2,080
| +5% | +$15.3K | ﹤0.01% | 1774 |
|
|
2025
Q1 | $390K | Sell |
43,200
-3,141
| -7% | -$33.2K | ﹤0.01% | 1842 |
|
|
2024
Q4 | $606K | Buy |
46,341
+3,176
| +7% | +$42.3K | ﹤0.01% | 1696 |
|
|
2024
Q3 | $677K | Hold |
43,165
| – | – | ﹤0.01% | 1615 |
|
|
2024
Q2 | $583K | Buy |
43,165
+4,988
| +13% | +$102K | ﹤0.01% | 1641 |
|
|
2024
Q1 | $1.06M | Hold |
38,177
| – | – | 0.01% | 1266 |
|
|
2023
Q4 | $736K | Hold |
38,177
| – | – | 0.01% | 1467 |
|
|
2023
Q3 | $617K | Hold |
38,177
| – | – | ﹤0.01% | 1500 |
|
|
2023
Q2 | $727K | Sell |
38,177
-2,067
| -5% | -$36.9K | 0.01% | 1450 |
|
|
2023
Q1 | $586K | Hold |
40,244
| – | – | ﹤0.01% | 1547 |
|
|
2022
Q4 | $786K | Hold |
40,244
| – | – | 0.01% | 1345 |
|
|
2022
Q3 | $970K | Buy |
40,244
+2,324
| +6% | +$71.6K | 0.01% | 1207 |
|
|
2022
Q2 | $1.19M | Sell |
37,920
-1,020
| -3% | -$36.9K | 0.01% | 1122 |
|
|
2022
Q1 | $1.71M | Buy |
38,940
+12,831
| +49% | +$551K | 0.01% | 1057 |
|
|
2021
Q4 | $1.14M | Hold |
26,109
| – | – | 0.01% | 1077 |
|
|
2021
Q3 | $817K | Hold |
26,109
| – | – | 0.01% | 1235 |
|
|
2021
Q2 | $1.11M | Sell |
26,109
-3,477
| -12% | -$135K | 0.01% | 1103 |
|
|
2021
Q1 | $1.11M | Hold |
29,586
| – | – | 0.01% | 1107 |
|
|
2020
Q4 | $800K | Sell |
29,586
-1,372
| -4% | -$35.3K | 0.01% | 1232 |
|
|
2020
Q3 | $777K | Hold |
30,958
| – | – | 0.01% | 1153 |
|
|
2020
Q2 | $236K | Hold |
30,958
| – | – | ﹤0.01% | 1801 |
|
|
2020
Q1 | $283K | Hold |
30,958
| – | – | ﹤0.01% | 1503 |
|
|
2019
Q4 | $160K | Hold |
30,958
| – | – | ﹤0.01% | 2097 |
|
|
2019
Q3 | $180K | Buy |
30,958
+2,483
| +9% | +$11.1K | ﹤0.01% | 2009 |
|
|
2019
Q2 | $91.1K | Hold |
28,475
| – | – | ﹤0.01% | 2387 |
|
|
2019
Q1 | $117K | Hold |
28,475
| – | – | ﹤0.01% | 2257 |
|
|
2018
Q4 | $180K | Hold |
28,475
| – | – | ﹤0.01% | 1970 |
|
|
2018
Q3 | $470K | Hold |
28,475
| – | – | ﹤0.01% | 1582 |
|
|
2018
Q2 | $476K | Hold |
28,475
| – | – | 0.01% | 1429 |
|
|
2018
Q1 | $443K | Sell |
28,475
-38,753
| -58% | -$691K | 0.01% | 1440 |
|
|
2017
Q4 | $1.27M | Buy |
+67,228
| New | +$1.49M | 0.01% | 938 |
|
Other funds holding ACH
CCM
ICM
PCMI
MetLife Investment Management's ACH Position: Q2 2026 in Review
MetLife Investment Management reduced its Accendra Health (ACH) stake by 1.8% in Q2 2026, selling an estimated $2.34K and leaving 41,729 shares worth $143K. The position accounts for ﹤0.01% of the portfolio, ranked #2603.
MetLife Investment Management first reported a position in ACH in Q4 2017 and has held it in 35 quarters since. The position peaked at $1.71M in Q1 2022. 139 funds tracked by Wall St. Rank hold ACH as of Q2 2026.
- MetLife Investment Management held 41,729 shares of Accendra Health worth $143K as of Q2 2026.
- MetLife Investment Management sold 754 Accendra Health shares in Q2 2026, an estimated $2.34K.
- Accendra Health made up ﹤0.01% of MetLife Investment Management's portfolio in Q2 2026, its #2603 holding.
- MetLife Investment Management first reported a position in Accendra Health in Q4 2017 and has held it in 35 quarters since.
- MetLife Investment Management's Accendra Health position peaked at $1.71M in Q1 2022.
- 139 funds tracked by Wall St. Rank held Accendra Health as of Q2 2026.
Based on MetLife Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.